Jin Gu

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Gang Yang · 3 shared papers, 2020–2025 · strength 0.42
   • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
   • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
   • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗
2. Taiping Zhang · 3 shared papers, 2020–2025 · strength 0.42
   • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
   • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
   • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗
3. Lei You · 3 shared papers, 2020–2025 · strength 0.42
   • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
   • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
   • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗
4. Jiangdong Qiu · 2 shared papers, 2021–2025 · strength 0.32
   • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
   • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
5. Fangyu Zhao · 2 shared papers, 2020–2021 · strength 0.21
   • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
   • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗
6. Yupei Zhao · 2 shared papers, 2020–2021 · strength 0.21
   • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
   • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗
7. Jinxin Tao · 1 shared paper, 2025 · strength 0.21
   • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
8. Bo Xu Ren · 1 shared paper, 2025 · strength 0.21
   • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
9. Hao Chen · 1 shared paper, 2025 · strength 0.21
   • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
10. Xinqi Li · 1 shared paper, 2025 · strength 0.21
    • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
11. Guangyu Chen · 1 shared paper, 2025 · strength 0.21
    • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
12. Yu-Pei Zhao · 1 shared paper, 2025 · strength 0.21
    • Paper Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context gr… DOI 10.1016/j.canlet.2025.217751↗
13. Mengyu Feng · 1 shared paper, 2021 · strength 0.11
    • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
14. Guangbing Xiong · 1 shared paper, 2021 · strength 0.11
    • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
15. Yueze Liu · 1 shared paper, 2021 · strength 0.11
    • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
16. Zhe Cao · 1 shared paper, 2021 · strength 0.11
    • Paper Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. DOI 10.1158/1078-0432.ccr-19-3975↗
17. Francesca Ricciardiello · 1 shared paper, 2020 · strength 0.10
    • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗
18. Quanxiao Li · 1 shared paper, 2020 · strength 0.10
    • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗
19. Ferdinando Chiaradonna · 1 shared paper, 2020 · strength 0.10
    • Paper Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response a… DOI 10.1038/s41388-020-1260-1↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.